国缆检测 reported revenue of ¥0.19B for the period ended 2026-06-30, +12.4% year on year. Net income was ¥0.06B, a 30.0% net margin on a 61.0% gross margin. The largest revenue line is 检验检测 at 90% of the total. Free cash flow for the period was ¥0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.19B | +12.4% |
| Gross profit | ¥0.12B | — |
| Operating income | ¥0.07B | — |
| Net income | ¥0.06B | +20.0% |
| Gross margin | 61.0% | Net margin 30.0% |
| Revenue Q/Q | +12.3% | — |
| Segment | Revenue | Share |
|---|---|---|
| 检验检测 | ¥0.17B | 89.7% |
| 其他(补充) | ¥0.01B | 6.1% |
| 计量 | ¥0.01B | 3.4% |
| 技术服务 | ¥0.00B | 0.8% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.07B | 39.0% |
| R&D | ¥0.01B | 7.9% |
| SG&A | ¥0.03B | 16.0% |
| Tax & other | ¥0.01B | 4.9% |
| Item | Amount |
|---|---|
| Total assets | ¥1.39B |
| Total liabilities | ¥0.27B |
| Shareholders' equity | ¥1.12B |
| Equity / assets | 80.5% |
| Operating cash flow | ¥0.06B |
| Capital expenditure | ¥0.05B |
| Free cash flow | ¥0.01B |
| Cash conversion (OCF / net income) | 142% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
东星医疗 ・ 明阳电气 ・ 海科新源 ・ 三博脑科 ・ 美硕科技 ・ 新巨丰 ・ 富乐德 ・ 东利机械 ・ 卓创资讯 ・ 远翔新材 ・ 川宁生物 ・ 华如科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies